-
1
-
-
0031597891
-
Buccal mucosa as a route for systemic drug delivery: A review
-
Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Sci 1998; 1 (1): 15-30
-
(1998)
J Pharm Sci
, vol.1
, Issue.1
, pp. 15-30
-
-
Shojaei, A.H.1
-
2
-
-
5144234094
-
Mucosal drug delivery: Membranes, methodologies and applications
-
Song Y, Wang Y, Thakur R, et al. Mucosal drug delivery: membranes, methodologies and applications. Crit Rev Ther Drug Carrier Syst 2004; 21 (3): 195-256
-
(2004)
Crit Rev Ther Drug Carrier Syst
, vol.21
, Issue.3
, pp. 195-256
-
-
Song, Y.1
Wang, Y.2
Thakur, R.3
-
3
-
-
0025864459
-
Absorption of drug from the human oral cavity
-
Rathbone MJ, Hadgraft J. Absorption of drug from the human oral cavity. Int J Pharm 1991; 74: 9-24
-
(1991)
Int J Pharm
, vol.74
, pp. 9-24
-
-
Rathbone, M.J.1
Hadgraft, J.2
-
4
-
-
0026564618
-
Drug delivery via the mucous membranes of the oral cavity
-
Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992; 81: 1-10
-
(1992)
J Pharm Sci
, vol.81
, pp. 1-10
-
-
Harris, D.1
Robinson, J.R.2
-
7
-
-
0029757133
-
Systemic delivery of peptides and proteins across absorp tive mucosae
-
Sayani AP, Chien YW. Systemic delivery of peptides and proteins across absorp tive mucosae. Crit Rev Ther Drug Carrier Syst 1996; 13 (1, 2): 85-184
-
(1996)
Crit Rev Ther Drug Carrier Syst
, vol.13
, Issue.1-2
, pp. 85-184
-
-
Sayani, A.P.1
Chien, Y.W.2
-
8
-
-
0003070827
-
Structure and function of the oral mucosa and implications for drug delivery
-
Rathbone MJ, editor. New York: Marcel Dekker
-
Squier CA, Wertz PW. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ, editor. Oral mucosal drug delivery. New York: Marcel Dekker, 1996: 1-25
-
(1996)
Oral Mucosal Drug Delivery
, pp. 1-25
-
-
Squier, C.A.1
Wertz, P.W.2
-
9
-
-
0035858298
-
Drug penetration enhancement via buccal route: Possibilities and limitations
-
Senel S, Hincal AA. Drug penetration enhancement via buccal route: possibilities and limitations. J Control Release 2001; 72: 133-44
-
(2001)
J Control Release
, vol.72
, pp. 133-144
-
-
Senel, S.1
Hincal, A.A.2
-
11
-
-
0002637956
-
Biochemical basis of the permeability barrier in skin and oral mucosa
-
Rathbone MJ, editor. New York: Marcel Dekker
-
Wertz PW, Hoogstraate AJ, Squier CA. Biochemical basis of the permeability barrier in skin and oral mucosa. In: Rathbone MJ, editor. Oral mucosal drug delivery. New York: Marcel Dekker, 1996: 27-49
-
(1996)
Oral Mucosal Drug Delivery
, pp. 27-49
-
-
Wertz, P.W.1
Hoogstraate, A.J.2
Squier, C.A.3
-
12
-
-
0025599403
-
Insulin and proinsulin in mucosal homogenates of the albino rabbit: Implications in peptide delivery from normal routes
-
Yamamoto A, Hayakawa E, Lee VHL. Insulin and proinsulin in mucosal homogenates of the albino rabbit: implications in peptide delivery from normal routes. Life Sci 1990; 47: 2465-74
-
(1990)
Life Sci
, vol.47
, pp. 2465-2474
-
-
Yamamoto, A.1
Hayakawa, E.2
Lee, V.H.L.3
-
13
-
-
0026672148
-
Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro
-
Dowthy ME, Knuth KE, Irons BK, et al. Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharm Res 1992; 9: 1113-22
-
(1992)
Pharm Res
, vol.9
, pp. 1113-1122
-
-
Dowthy, M.E.1
Knuth, K.E.2
Irons, B.K.3
-
14
-
-
0034630914
-
TR146 cells grown on filters as a model of human buccal epithelium: V. Enzyme activity of the TR146 cell culture model, human buccal epithelium and porcine buccal epithelium, and permeability of leuenkephalin
-
Nielsen HM, Rassing MR. TR146 cells grown on filters as a model of human buccal epithelium: V. Enzyme activity of the TR146 cell culture model, human buccal epithelium and porcine buccal epithelium, and permeability of leuenkephalin. Int J Pharm 2000; 200: 261-70
-
(2000)
Int J Pharm
, vol.200
, pp. 261-270
-
-
Nielsen, H.M.1
Rassing, M.R.2
-
15
-
-
0027686733
-
Mechanisms, barriers and pathways of oral mucosal drug permeation
-
Rathbone MJ, Tucker IG. Mechanisms, barriers and pathways of oral mucosal drug permeation. Adv Drug Deliv Rev 1993; 13: 1-22
-
(1993)
Adv Drug Deliv Rev
, vol.13
, pp. 1-22
-
-
Rathbone, M.J.1
Tucker, I.G.2
-
16
-
-
0031916032
-
Permeation of unfolded basic fibroblast growth factor (βFGF) across rabbit buccal mucosa: Does unfolding of βFGF enhance transport?
-
Johnston TP, Rahman A, Alur H, et al. Permeation of unfolded basic fibroblast growth factor (βFGF) across rabbit buccal mucosa: does unfolding of βFGF enhance transport? Pharm Res 1998; 15: 246-53
-
(1998)
Pharm Res
, vol.15
, pp. 246-253
-
-
Johnston, T.P.1
Rahman, A.2
Alur, H.3
-
17
-
-
0037148692
-
Peptidase activity on the surface of the porcine buccal mucosa
-
Walker GF, Langoth N, Bernkop-Schnurch A. Peptidase activity on the surface of the porcine buccal mucosa. Int J Pharm 2002; 233: 141-7
-
(2002)
Int J Pharm
, vol.233
, pp. 141-147
-
-
Walker, G.F.1
Langoth, N.2
Bernkop-Schnurch, A.3
-
18
-
-
0035132416
-
Factors and strategies for improving buccal absorption of peptides
-
Veuillez F, Kalia YN, Jacques Y, et al. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm 2001; 51: 93-109
-
(2001)
Eur J Pharm Biopharm
, vol.51
, pp. 93-109
-
-
Veuillez, F.1
Kalia, Y.N.2
Jacques, Y.3
-
19
-
-
0032144026
-
Comparison of ex-vivo oral mucosal permeation of tryptophan-leucine (Trp-leu) and its myristoyl derivative
-
Veuillez F, Ganem-Quintanar A, Deshusses J, et al. Comparison of ex-vivo oral mucosal permeation of tryptophan-leucine (Trp-leu) and its myristoyl derivative. Int J Pharm 1998; 170: 85-91
-
(1998)
Int J Pharm
, vol.170
, pp. 85-91
-
-
Veuillez, F.1
Ganem-Quintanar, A.2
Deshusses, J.3
-
20
-
-
0023578505
-
Preliminary studies of oral mucosal delivery of peptide drugs
-
Veillard MM, Longer MA, Martens TW, et al. Preliminary studies of oral mucosal delivery of peptide drugs. J Control Release 1987; 6: 123-31
-
(1987)
J Control Release
, vol.6
, pp. 123-131
-
-
Veillard, M.M.1
Longer, M.A.2
Martens, T.W.3
-
21
-
-
0025800582
-
Permeaselective characteristics of rabbit buccal mucosa
-
Gandhi RB, Robinson JR. Permeaselective characteristics of rabbit buccal mucosa. Pharm Res 1991; 8 (9): 1199-202
-
(1991)
Pharm Res
, vol.8
, Issue.9
, pp. 1199-1202
-
-
Gandhi, R.B.1
Robinson, J.R.2
-
23
-
-
0141653632
-
Peptides and proteins: Buccal absorption
-
Swarbrick J, Boylan JC, editors. New York: Marcel Dekker Inc
-
Alur HH, Johnston TP, Mitra AK. Peptides and proteins: buccal absorption. In: Swarbrick J, Boylan JC, editors. Enciclopedia of pharmaceutical technology. New York: Marcel Dekker Inc, 2001; 20 Suppl. 3: 193-218
-
(2001)
Enciclopedia of Pharmaceutical Technology
, vol.20
, Issue.3 SUPPL.
, pp. 193-218
-
-
Alur, H.H.1
Johnston, T.P.2
Mitra, A.K.3
-
25
-
-
0028011008
-
An in vivo dog model for studying recovery kinetics of buccal mucosa permeation barrier after exposure to permeation enhancers: Apparent evidence of effective enhancement without tissue damage
-
Zhang J, Niu S, Ebert C, et al. An in vivo dog model for studying recovery kinetics of buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage. Int J Pharm 1994; 101: 15-22
-
(1994)
Int J Pharm
, vol.101
, pp. 15-22
-
-
Zhang, J.1
Niu, S.2
Ebert, C.3
-
26
-
-
0037093768
-
Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea pigs
-
Tsutsumi K, Obata Y, Nagai T, et al. Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea pigs. Int J Pharm 2002; 238 (1, 2): 161-70
-
(2002)
Int J Pharm
, vol.238
, Issue.1-2
, pp. 161-170
-
-
Tsutsumi, K.1
Obata, Y.2
Nagai, T.3
-
27
-
-
0002909949
-
Oral mucosal penetration enhancement: Possibilities and limitations
-
Rathbone MJ, editors. New York: Marcel Dekker
-
Aungst BJ. Oral mucosal penetration enhancement: possibilities and limitations. In: Rathbone MJ, editors. Oral mucosal drug delivery. New York: Marcel Dekker, 1996: 65-83
-
(1996)
Oral Mucosal Drug Delivery
, pp. 65-83
-
-
Aungst, B.J.1
-
28
-
-
0028215122
-
Site-dependence and structure-effect relationships for alkylglycosides as transmucosal absorption promoters for insulin
-
Aungst BJ. Site-dependence and structure-effect relationships for alkylglycosides as transmucosal absorption promoters for insulin. Int J Pharm 1994; 105: 219-25
-
(1994)
Int J Pharm
, vol.105
, pp. 219-225
-
-
Aungst, B.J.1
-
29
-
-
0023888769
-
2 EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery
-
2 EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm Res 1988; 5: 308
-
(1988)
Pharm Res
, vol.5
, pp. 308
-
-
Aungst, B.J.1
Rogers, N.J.2
-
30
-
-
0024371793
-
Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery
-
Aungst BJ, Rogers NJ. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int J Pharm 1989; 53: 227-35
-
(1989)
Int J Pharm
, vol.53
, pp. 227-235
-
-
Aungst, B.J.1
Rogers, N.J.2
-
31
-
-
0025113804
-
Protease inhibitors and penetration enhancers as approaches to modify peptide absorption
-
Lee VH. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J Control Release 1990; 13: 213-23
-
(1990)
J Control Release
, vol.13
, pp. 213-223
-
-
Lee, V.H.1
-
32
-
-
0023930592
-
Comparison of nasal, rectal, buccal, sublingual and intramuscolar insulin efficacy and the effects of a bile salts absorption promoter
-
Aungst BJ, Rogers NJ, Shefter E. Comparison of nasal, rectal, buccal, sublingual and intramuscolar insulin efficacy and the effects of a bile salts absorption promoter. J Pharmacol Exp Ther 1988; 244: 23-7
-
(1988)
J Pharmacol Exp Ther
, vol.244
, pp. 23-27
-
-
Aungst, B.J.1
Rogers, N.J.2
Shefter, E.3
-
34
-
-
0029759228
-
In vivo buccal delivery of peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs
-
Hoogstraate JA, Verhoef JC, Pijpers A, et al. In vivo buccal delivery of peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm Res 1996; 13: 1233-7
-
(1996)
Pharm Res
, vol.13
, pp. 1233-1237
-
-
Hoogstraate, J.A.1
Verhoef, J.C.2
Pijpers, A.3
-
35
-
-
0028209127
-
The effect of enhancers on the buccal absorption of hydrid (BDBB) alpha-interferon
-
Steward A, Bayley DL, Howes C. The effect of enhancers on the buccal absorption of hydrid (BDBB) alpha-interferon. Int J Pharm 1994; 104: 145-9
-
(1994)
Int J Pharm
, vol.104
, pp. 145-149
-
-
Steward, A.1
Bayley, D.L.2
Howes, C.3
-
36
-
-
0030572644
-
Mechanism of action of skin penetration enhancers/retarders: Azone and analogues
-
Hadgraft J, Peck J, William DG, et al. Mechanism of action of skin penetration enhancers/retarders: azone and analogues. Int J Pharm 1996; 141: 17-25
-
(1996)
Int J Pharm
, vol.141
, pp. 17-25
-
-
Hadgraft, J.1
Peck, J.2
William, D.G.3
-
38
-
-
0028281787
-
Effect of some penetration enhancers on epithelial membrane lipid domains: Evidence from fluorescence spectroscopy studies
-
Turunen TM, Urtti A, Paronen P, et al. Effect of some penetration enhancers on epithelial membrane lipid domains: evidence from fluorescence spectroscopy studies. Pharm Res 1994; 11: 288-94
-
(1994)
Pharm Res
, vol.11
, pp. 288-294
-
-
Turunen, T.M.1
Urtti, A.2
Paronen, P.3
-
39
-
-
0031695851
-
Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol
-
Morgan TM, O'Sullivan HM, Reed BL, et al. Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol. J Pharm Sci 1998; 87: 1226-8
-
(1998)
J Pharm Sci
, vol.87
, pp. 1226-1228
-
-
Morgan, T.M.1
O'Sullivan, H.M.2
Reed, B.L.3
-
40
-
-
3843104844
-
Modification of buccal drug delivery following pre-treatment with skin penetration enhancers
-
Nicolazzo JA, Reed BL, Finnin BC. Modification of buccal drug delivery following pre-treatment with skin penetration enhancers. J Pharm Sci 2004; 93 (8): 2054-63
-
(2004)
J Pharm Sci
, vol.93
, Issue.8
, pp. 2054-2063
-
-
Nicolazzo, J.A.1
Reed, B.L.2
Finnin, B.C.3
-
41
-
-
0031783879
-
Chitosan and its use as a phamaceutical excipient
-
Illum L. Chitosan and its use as a phamaceutical excipient. Pharm Res 1998; 15 (9): 1326-31
-
(1998)
Pharm Res
, vol.15
, Issue.9
, pp. 1326-1331
-
-
Illum, L.1
-
42
-
-
0033991816
-
Chitosan and its derivatives: Potential excipients for peroral peptide delivery systems
-
Bernkop-Schnurch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm 2000; 194: 1-13
-
(2000)
Int J Pharm
, vol.194
, pp. 1-13
-
-
Bernkop-Schnurch, A.1
-
43
-
-
0034002445
-
Chitosan as nasal absorption enhancers of peptides: Comparison between free amine chitosans and soluble salts
-
Tengamnuay P, Sahamethapat A, Sailasuta A, et al. Chitosan as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm 2000; 197: 53-67
-
(2000)
Int J Pharm
, vol.197
, pp. 53-67
-
-
Tengamnuay, P.1
Sahamethapat, A.2
Sailasuta, A.3
-
44
-
-
0034308327
-
Enhancing effect of chitosan on peptide drug delivery across buccal mucosa
-
Senel S, Kremer MJ, Kas S, et al. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 2000; 21: 2067-71
-
(2000)
Biomaterials
, vol.21
, pp. 2067-2071
-
-
Senel, S.1
Kremer, M.J.2
Kas, S.3
-
45
-
-
0038669001
-
Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid
-
Rossi S, Sandri G, Ferrari F, et al. Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Pharm Dev Technol 2003; 8 (2): 199-208
-
(2003)
Pharm Dev Technol
, vol.8
, Issue.2
, pp. 199-208
-
-
Rossi, S.1
Sandri, G.2
Ferrari, F.3
-
46
-
-
0345055299
-
Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2)
-
Kotze AF, LueBen HL, de Leeuw BJ, et al. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release 1998; 51: 35-46
-
(1998)
J Control Release
, vol.51
, pp. 35-46
-
-
Kotze, A.F.1
LueBen, H.L.2
De Leeuw, B.J.3
-
47
-
-
0034002707
-
Enhancement of paracellular drug trasport across mucosal epithelia by N-trimethyl chitosan chloride
-
Hamman J, Stander J, Junginger HE, et al. Enhancement of paracellular drug trasport across mucosal epithelia by N-trimethyl chitosan chloride. STP Pharma Sci 2000; 10 (1): 35-8
-
(2000)
STP Pharma Sci
, vol.10
, Issue.1
, pp. 35-38
-
-
Hamman, J.1
Stander, J.2
Junginger, H.E.3
-
48
-
-
0035171635
-
Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo
-
Thanou M, Nihot MT, Jansen M, et al. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. J Pharm Sci 2001; 90 (1): 38-46
-
(2001)
J Pharm Sci
, vol.90
, Issue.1
, pp. 38-46
-
-
Thanou, M.1
Nihot, M.T.2
Jansen, M.3
-
49
-
-
0742304305
-
Assessment of chitosan derivatives as buccal and vaginal penetration enhancers
-
Sandri G, Rossi S, Ferrari F, et al. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur J Pharm Sci 2004; 21: 351-9
-
(2004)
Eur J Pharm Sci
, vol.21
, pp. 351-359
-
-
Sandri, G.1
Rossi, S.2
Ferrari, F.3
-
50
-
-
19344364333
-
Buccal penetration enhancement properties of trimethyl-chitosan
-
Sandri G, Rossi S, Ferrari F, et al. Buccal penetration enhancement properties of trimethyl-chitosan. Int J Pharm 2005; 297 (1-2): 146-55
-
(2005)
Int J Pharm
, vol.297
, Issue.1-2
, pp. 146-155
-
-
Sandri, G.1
Rossi, S.2
Ferrari, F.3
-
51
-
-
0032917517
-
Effect of chitosan on epithelial permeability and structure
-
Dodane V, Amin Khan M, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999; 182: 21-32
-
(1999)
Int J Pharm
, vol.182
, pp. 21-32
-
-
Dodane, V.1
Amin Khan, M.2
Merwin, J.R.3
-
53
-
-
17344382638
-
Mucoadhesive polymers in peroral peptide drug delivery: I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes
-
Lueßen HL, de Leeuw BJ, Perard D, et al. Mucoadhesive polymers in peroral peptide drug delivery: I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes. Eur J Pharm Sci 1996, 128
-
(1996)
Eur J Pharm Sci
, pp. 128
-
-
Lueßen, H.L.1
De Leeuw, B.J.2
Perard, D.3
-
54
-
-
0032812720
-
Carbomer inhibits tryptic proteolysis of luteinizing hormone-releasing hormone and n-alpha-benzoyl-L-arginine ethyl ester by binding the enzyme
-
Walker GF, Ledger R, Tucker IG. Carbomer inhibits tryptic proteolysis of luteinizing hormone-releasing hormone and n-alpha-benzoyl-L-arginine ethyl ester by binding the enzyme. Pharm Res 1999; 16 (7): 1074-80
-
(1999)
Pharm Res
, vol.16
, Issue.7
, pp. 1074-1080
-
-
Walker, G.F.1
Ledger, R.2
Tucker, I.G.3
-
55
-
-
0030740816
-
Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N
-
Bernkop-Schnurch A, Paikl C, Valenta C. Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N. Pharm Res 1997; 14 (7): 917-22
-
(1997)
Pharm Res
, vol.14
, Issue.7
, pp. 917-922
-
-
Bernkop-Schnurch, A.1
Paikl, C.2
Valenta, C.3
-
56
-
-
0348026751
-
In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix
-
Guggi D, Kast CE, Bernkop-Schnurch A. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix. Pharm Res 2003; 20 (12): 1989-94
-
(2003)
Pharm Res
, vol.20
, Issue.12
, pp. 1989-1994
-
-
Guggi, D.1
Kast, C.E.2
Bernkop-Schnurch, A.3
-
57
-
-
3843126497
-
Thiomers: Potential excipients for non-invasive peptide delivery systems
-
Berknop-Schnurch A, Krauland AH, Leitner VM, et al. Thiomers: potential excipients for non-invasive peptide delivery systems. Eur J Pharm Biopharm 2004; 58: 253-63
-
(2004)
Eur J Pharm Biopharm
, vol.58
, pp. 253-263
-
-
Berknop-Schnurch, A.1
Krauland, A.H.2
Leitner, V.M.3
-
58
-
-
0003083394
-
The role of water movement and polymer hydration in mucoadhesion
-
Mathiowitz E, Chickering III DE, Lehr CM, editors, New York: Marcel Dekker
-
Smart JD. The role of water movement and polymer hydration in mucoadhesion. In: Mathiowitz E, Chickering III DE, Lehr CM, editors, Bioadhesive drug delivery systems. New York: Marcel Dekker, 1999: 11-23
-
(1999)
Bioadhesive Drug Delivery Systems
, pp. 11-23
-
-
Smart, J.D.1
-
59
-
-
1542614043
-
Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease
-
Perioli L, Ambrogi V, Rubini D, et al. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004; 95 (3): 521-33
-
(2004)
J Control Release
, vol.95
, Issue.3
, pp. 521-533
-
-
Perioli, L.1
Ambrogi, V.2
Rubini, D.3
-
60
-
-
0142245748
-
Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride
-
Nafee NA, Boraie NA, Ismail FA, et al. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharmaceutica 2003; 53 (3): 199-212
-
(2003)
Acta Pharmaceutica
, vol.53
, Issue.3
, pp. 199-212
-
-
Nafee, N.A.1
Boraie, N.A.2
Ismail, F.A.3
-
61
-
-
0142060267
-
Mucoadhesive buccal patches of miconazole nitrate: In vitro/in vivo performance and effect of ageing
-
Nafee NA, Ismail FA, Boraie NA, et al. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm 2003; 264 (1-2): 1-14
-
(2003)
Int J Pharm
, vol.264
, Issue.1-2
, pp. 1-14
-
-
Nafee, N.A.1
Ismail, F.A.2
Boraie, N.A.3
-
62
-
-
0034836503
-
Formulation and evaluation of buccal mucoadhesive patches of terbutaline sulfate
-
Sharma P, Hamsa V. Formulation and evaluation of buccal mucoadhesive patches of terbutaline sulfate. STP Pharma Sci 2001; 11 (4): 275-81
-
(2001)
STP Pharma Sci
, vol.11
, Issue.4
, pp. 275-281
-
-
Sharma, P.1
Hamsa, V.2
-
63
-
-
0035069282
-
Design and evaluation of a new mucoadhesive bi-layered tablet containing nimesulide for buccal administration
-
Ceschel GC, Maffei P, Lombardi Borgia S. Design and evaluation of a new mucoadhesive bi-layered tablet containing nimesulide for buccal administration. STP Pharma Sci 2001; 11 (2): 151-6
-
(2001)
STP Pharma Sci
, vol.11
, Issue.2
, pp. 151-156
-
-
Ceschel, G.C.1
Maffei, P.2
Lombardi Borgia, S.3
-
64
-
-
0033044790
-
Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: Effect of formulation variables on drug release and mucoadhesive performance
-
Han RY, Fang JY, Sung KC, et al. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm 1999; 177 (2): 201-9
-
(1999)
Int J Pharm
, vol.177
, Issue.2
, pp. 201-209
-
-
Han, R.Y.1
Fang, J.Y.2
Sung, K.C.3
-
65
-
-
0034601107
-
Evaluation of poly(acrylic acid-co-ethylhexyl acrylate) films for mucoadhesive transbuccal drug delivery: Factors affecting the force of mucoadhesion
-
Shojaei AH, Paulson J, Honary S. Evaluation of poly(acrylic acid-co-ethylhexyl acrylate) films for mucoadhesive transbuccal drug delivery: factors affecting the force of mucoadhesion. J Control Release 2000; 67 (2-3): 223-32
-
(2000)
J Control Release
, vol.67
, Issue.2-3
, pp. 223-232
-
-
Shojaei, A.H.1
Paulson, J.2
Honary, S.3
-
66
-
-
26644434055
-
Novel PEG-containing acrylate copolymers with improved mucoadhesive properties
-
Mathiowitz E, Chickering III DE, Lehr CM editors. New York: Marcel Dekker
-
Shojaei AH, Li X. Novel PEG-containing acrylate copolymers with improved mucoadhesive properties. In: Mathiowitz E, Chickering III DE, Lehr CM editors. Bioadhesive drug delivery systems. New York: Marcel Dekker, 1999: 433-58
-
(1999)
Bioadhesive Drug Delivery Systems
, pp. 433-458
-
-
Shojaei, A.H.1
Li, X.2
-
67
-
-
0028335674
-
Formulation of buccal mucoadhesive dosage form of ergotamine tartrate
-
Tsutsumi K, Takayama K, Machida Y, et al. Formulation of buccal mucoadhesive dosage form of ergotamine tartrate. STP Pharma Sci 1994; 4 (3): 230-4
-
(1994)
STP Pharma Sci
, vol.4
, Issue.3
, pp. 230-234
-
-
Tsutsumi, K.1
Takayama, K.2
Machida, Y.3
-
68
-
-
0037139414
-
Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis
-
Kinci G, Senel S, Akincibay H, et al. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharm 2002; 235 (1-2): 121-7
-
(2002)
Int J Pharm
, vol.235
, Issue.1-2
, pp. 121-127
-
-
Kinci, G.1
Senel, S.2
Akincibay, H.3
-
69
-
-
0032839408
-
An in vitro mucosal model predictive of bioadhesive agents in the oral cavity
-
Patel D, Smith AW, Grist N, et al. An in vitro mucosal model predictive of bioadhesive agents in the oral cavity. J Control Release 1999; 61 (1-2): 175-83
-
(1999)
J Control Release
, vol.61
, Issue.1-2
, pp. 175-183
-
-
Patel, D.1
Smith, A.W.2
Grist, N.3
-
70
-
-
4444339112
-
Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum
-
Sandri G, Rossi S, Ferrari F, et al. Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum. J Pharm Pharmacol 2004; 56 (9): 1083-90
-
(2004)
J Pharm Pharmacol
, vol.56
, Issue.9
, pp. 1083-1090
-
-
Sandri, G.1
Rossi, S.2
Ferrari, F.3
-
71
-
-
0037452411
-
Development of buccal drug delivery systems based on a thiolated polymer
-
Langoht N, Kalbe J, Berknop-Schnurch A. Development of buccal drug delivery systems based on a thiolated polymer. Int J Pharm 2003; 252: 141-8
-
(2003)
Int J Pharm
, vol.252
, pp. 141-148
-
-
Langoht, N.1
Kalbe, J.2
Berknop-Schnurch, A.3
-
72
-
-
0036411670
-
Peptide washout and permeability from glyceryl monooleate buccal delivery systems
-
Lee J, Kellaway IW. Peptide washout and permeability from glyceryl monooleate buccal delivery systems. Drug Dev Ind Pharm 2002; 28 (9): 1155-62
-
(2002)
Drug Dev Ind Pharm
, vol.28
, Issue.9
, pp. 1155-1162
-
-
Lee, J.1
Kellaway, I.W.2
-
73
-
-
1142273199
-
Lectin-mediated drug delivery in the oral cavity
-
Smart JD. Lectin-mediated drug delivery in the oral cavity. Adv Drug Deliv Rev 2004; 56: 481-9
-
(2004)
Adv Drug Deliv Rev
, vol.56
, pp. 481-489
-
-
Smart, J.D.1
-
74
-
-
0031470733
-
Lectines for drug delivery within the oral cavity-investigation of lectin binding to oral mucosa
-
Nantwi PKK, Cook DJ, Rogers DJ, et al. Lectines for drug delivery within the oral cavity-investigation of lectin binding to oral mucosa. J Drug Target 1997; 5: 45-55
-
(1997)
J Drug Target
, vol.5
, pp. 45-55
-
-
Nantwi, P.K.K.1
Cook, D.J.2
Rogers, D.J.3
-
75
-
-
0036219982
-
A quantitative evaluation of radiolabelled lectin retention on oral mucosa in vitro and in vivo
-
Smart JD, Nantwi PKK, Green DJ, et al. A quantitative evaluation of radiolabelled lectin retention on oral mucosa in vitro and in vivo. Eur J Pharm Biopharm 2002; 53: 289-92
-
(2002)
Eur J Pharm Biopharm
, vol.53
, pp. 289-292
-
-
Smart, J.D.1
Nantwi, P.K.K.2
Green, D.J.3
-
76
-
-
0019451183
-
New mucosal dosage form of insulin
-
Ishida M, Machida Y, Nambu N, et al. New mucosal dosage form of insulin. Chem Pharm Bull 1981; 29 (3): 810-6
-
(1981)
Chem Pharm Bull
, vol.29
, Issue.3
, pp. 810-816
-
-
Ishida, M.1
Machida, Y.2
Nambu, N.3
-
77
-
-
0022387167
-
Adhesive topical drug delivery system
-
Nagai T. Adhesive topical drug delivery system. J Control Release 1985; 2: 121-34
-
(1985)
J Control Release
, vol.2
, pp. 121-134
-
-
Nagai, T.1
-
79
-
-
0024836302
-
Penetration and enzymatic barriers to peptide and protein absorption
-
Lee VHL, Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Adv Drug Deliv Rev 1990; 4: 171-207
-
(1990)
Adv Drug Deliv Rev
, vol.4
, pp. 171-207
-
-
Lee, V.H.L.1
Yamamoto, A.2
-
80
-
-
0029840172
-
Potential therapeutic levels of glucagone-like peptide I achieved in humans by buccal tablet
-
Gutniak MK, Larsson H, Heiber SJ, et al. Potential therapeutic levels of glucagone-like peptide I achieved in humans by buccal tablet. Diabetes Care 1996; 19: 843-8
-
(1996)
Diabetes Care
, vol.19
, pp. 843-848
-
-
Gutniak, M.K.1
Larsson, H.2
Heiber, S.J.3
-
81
-
-
0032732323
-
Evaluation of a novel, matural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets
-
Alur HH, Beal JD, Pather SI, et al. Evaluation of a novel, matural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J Pharm Sci 1999; 88 (12): 1313-9
-
(1999)
J Pharm Sci
, vol.88
, Issue.12
, pp. 1313-1319
-
-
Alur, H.H.1
Beal, J.D.2
Pather, S.I.3
-
82
-
-
5644295636
-
Development of bioadhesive buccal patches
-
Mathiowitz E, ChicKering III DE, Lehr CM, editors. New York: Marcel Dekker
-
Guo JH, Cremer K. Development of bioadhesive buccal patches. In: Mathiowitz E, ChicKering III DE, Lehr CM, editors. Bioadhesive drug delivery systems. New York: Marcel Dekker, 1999: 541-562
-
(1999)
Bioadhesive Drug Delivery Systems
, pp. 541-562
-
-
Guo, J.H.1
Cremer, K.2
-
83
-
-
0025638991
-
Bioadhesive polymers in peptide drug delivery
-
Harris D, Robinson R. Bioadhesive polymers in peptide drug delivery. Biomaterials 1990; 11: 652-8
-
(1990)
Biomaterials
, vol.11
, pp. 652-658
-
-
Harris, D.1
Robinson, R.2
-
84
-
-
0030906544
-
Absorption of thyrotropin-releasing hormone in rats using a mucoadhesive buccal patch
-
Li C, Koch RL, Raul VA, et al. Absorption of thyrotropin-releasing hormone in rats using a mucoadhesive buccal patch. Drug Dev Ind Pharm 1997; 23 (3): 239-246
-
(1997)
Drug Dev Ind Pharm
, vol.23
, Issue.3
, pp. 239-246
-
-
Li, C.1
Koch, R.L.2
Raul, V.A.3
-
85
-
-
4244022813
-
Transbuccal delivery of a model tripeptide
-
Li C, Raul VA, Bhatt PP, et al. Transbuccal delivery of a model tripeptide [abstract]. Pharm Res 1993; 10: S201
-
(1993)
Pharm Res
, vol.10
-
-
Li, C.1
Raul, V.A.2
Bhatt, P.P.3
-
86
-
-
0024552779
-
Evaluation of laminated muco-adhesive patches for buccal delivery
-
Anders R, Merkle HP. Evaluation of laminated muco-adhesive patches for buccal delivery. Int J Pharm 1989; 49 (3): 231-40
-
(1989)
Int J Pharm
, vol.49
, Issue.3
, pp. 231-240
-
-
Anders, R.1
Merkle, H.P.2
-
87
-
-
4243276141
-
Mucoadhesive buccal patches for peptide delivery
-
Laenerts V, Gurney R, editors. Boca Raton (FL): CRC Press
-
Merkle HP, Anders R, Wermerskirchen A. Mucoadhesive buccal patches for peptide delivery. In: Laenerts V, Gurney R, editors. Bioadhesive drug delivery system. Boca Raton (FL): CRC Press, 1990: 105-36
-
(1990)
Bioadhesive Drug Delivery System
, pp. 105-136
-
-
Merkle, H.P.1
Anders, R.2
Wermerskirchen, A.3
-
88
-
-
0031392482
-
Transmucosal delivery of oxytocin to rabbits using mucoadhesive buccal patch
-
Li C, Bhatt PP, Johnston TP. Transmucosal delivery of oxytocin to rabbits using mucoadhesive buccal patch. Pharm Dev Technol 1997; 2: 265-74
-
(1997)
Pharm Dev Technol
, vol.2
, pp. 265-274
-
-
Li, C.1
Bhatt, P.P.2
Johnston, T.P.3
-
89
-
-
0029759228
-
In vivo buccal delivery of the peptide drug buserelin with glycodeoxy cholate as an absorption enhancer in pigs
-
Hoogstraate JA, Verhoef JC, Pijpers A, et al. In vivo buccal delivery of the peptide drug buserelin with glycodeoxy cholate as an absorption enhancer in pigs. Pharm Res 1996; 13: 1233-7
-
(1996)
Pharm Res
, vol.13
, pp. 1233-1237
-
-
Hoogstraate, J.A.1
Verhoef, J.C.2
Pijpers, A.3
-
90
-
-
4243999440
-
In vitro evaluation of buccal bioadhesive patches: I. systemic and local delivery of drugs
-
Chen W, Hwang GC. In vitro evaluation of buccal bioadhesive patches: I. systemic and local delivery of drugs [abstract]. Pharm Res 1993; 10: S202
-
(1993)
Pharm Res
, vol.10
-
-
Chen, W.1
Hwang, G.C.2
-
92
-
-
0036913714
-
Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites
-
Cui Z, Mumper RJ. Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites. Pharm Res 2002; 19 (2): 1901-6
-
(2002)
Pharm Res
, vol.19
, Issue.2
, pp. 1901-1906
-
-
Cui, Z.1
Mumper, R.J.2
-
93
-
-
0033969177
-
Buccal permeation of (D-Ala2, D-Leu5)enkephalin from liquid crystalline phases of glyceryl monooleate
-
Lee J, Kellaway IW. Buccal permeation of (D-Ala2, D-Leu5)enkephalin from liquid crystalline phases of glyceryl monooleate. Int J Pharm 2000; 195: 35-8
-
(2000)
Int J Pharm
, vol.195
, pp. 35-38
-
-
Lee, J.1
Kellaway, I.W.2
-
94
-
-
0036593597
-
Phospholipid deformable vesicles for buccal delivery of insulin
-
Tokyo
-
Yang TZ, Wang XT, Yan XY, et al. Phospholipid deformable vesicles for buccal delivery of insulin. Chem Pharm Bull (Tokyo) 2002; 50 (6): 749-53
-
(2002)
Chem Pharm Bull
, vol.50
, Issue.6
, pp. 749-753
-
-
Yang, T.Z.1
Wang, X.T.2
Yan, X.Y.3
-
95
-
-
0036103168
-
Evolving role of oral insulin in the treatment of diabetes using a novel rapidmist system
-
Modi P, Mihic M, Lewin A. Evolving role of oral insulin in the treatment of diabetes using a novel rapidmist system. Diabetes Metab Res Rev 2002; 18 (1): 38-42
-
(2002)
Diabetes Metab Res Rev
, vol.18
, Issue.1
, pp. 38-42
-
-
Modi, P.1
Mihic, M.2
Lewin, A.3
-
96
-
-
11144254615
-
Oral spray insulin in treatment of type 2 diabetes: A comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study
-
Guevara-Aguirre J, Guevara M, Saavedra J, et al. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study. Diabetes Metab Res Rev 2004; 20 (6): 472-8
-
(2004)
Diabetes Metab Res Rev
, vol.20
, Issue.6
, pp. 472-478
-
-
Guevara-Aguirre, J.1
Guevara, M.2
Saavedra, J.3
|